Dr. Harbison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6431 Fannin St
# Msb
Houston, TX 77030Phone+1 713-500-6714Fax+1 713-704-9301
Education & Training
Duke University HospitalResidency, Internal Medicine/Pediatrics, 2002 - 2006
McGovern Medical School at UTHealthClass of 2002
Certifications & Licensure
TX State Medical License 2008 - 2026
MI State Medical License 2006 - 2010
NC State Medical License 2002 - 2006
Publications & Presentations
PubMed
- 424 citationsBlockade of the Epidermal Growth Factor Receptor Signaling by a Novel Tyrosine Kinase Inhibitor Leads to Apoptosis of Endothelial Cells and Therapy of Human Pancreatic...Christiane J. Bruns, Carmen C. Solorzano, Matthew T. Harbison, Shutaro Ozawa, Rachel Tsan
Cancer Research. 2000-06-01 - 347 citationsEpidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiang...Christiane J. Bruns, Matthew T. Harbison, Darren W. Davis, Charles A. Portera, Rachel Tsan
Clinical Cancer Research. 2000-05-01 - 37 citationsTherapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide syn...Christiane J. Bruns, Hisashi Shinohara, Matthew T. Harbison, Darren W. Davis, Gina M. Nelkin
Cancer Research. 2000-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
